{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:25:51Z","timestamp":1788873951829,"version":"build-2803163510"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.01166","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T23:25:06Z","timestamp":1547076306000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":110,"title":["Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know"],"prefix":"10.3389","volume":"9","author":[{"given":"Yang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B3","first-page":"S65","article-title":"Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides","volume":"27","author":"Zhang","year":"2009","journal-title":"Clin Exp Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.11387","article-title":"Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?","volume":"49","author":"Agard","year":"2003","journal-title":"Arthrit Rheum."},{"key":"B5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.rdc.2017.06.006","article-title":"Central nervous system disease in antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"43","author":"Graf","year":"2017","journal-title":"Rheum Dis Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","article-title":"Key advances in the clinical approach to ANCA-associated vasculitis","volume":"10","author":"Kallenberg","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/rheumatology\/kex367","article-title":"Towards precision medicine in ANCA-associated vasculitis","volume":"57","author":"van","year":"2018","journal-title":"Rheumatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.20452\/pamw.3598","article-title":"How to treat ANCAassociated vasculitis: practical messages from 2016 EULAR\/ERAEDTA recommendations","volume":"126","author":"Sznajd","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"B11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis \u2014 clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","article-title":"Neutrophil extracellular traps in ANCA-Associated Vasculitis","volume":"7","author":"Soderberg","year":"2016","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.autrev.2015.06.008","article-title":"Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides","volume":"14","author":"Dumoitier","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1038\/srep21931","article-title":"Transient increase of interleukin-1beta after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling","volume":"6","author":"Feng","year":"2016","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrn.2015.27","article-title":"Autoimmune synaptopathies","volume":"17","author":"Crisp","year":"2016","journal-title":"Nat Rev Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1756285609347123","article-title":"Diagnosis and treatment of cerebral vasculitis","volume":"3","author":"Berlit","year":"2010","journal-title":"Ther Adv Neurol Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fimmu.2013.00120","article-title":"The role of the innate immune system in granulomatous disorders","volume":"4","author":"Petersen","year":"2013","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener's granulomatosis","volume":"23","author":"Holle","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneur.1963.00460020045003","article-title":"Neurological Complications of Wegener's Granulomatosis","volume":"8","author":"Drachman","year":"1963","journal-title":"Arch Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/brain\/awt314","article-title":"Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"137","author":"Yokoseki","year":"2014","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10067-017-3835-y","article-title":"Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study","volume":"37","author":"Fragoulis","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.autrev.2016.07.016","article-title":"The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"15","author":"Weiner","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2006","journal-title":"Ann Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e7722","DOI":"10.1097\/MD.0000000000007722","article-title":"Medial medullary infarction caused by antineutrophil cytoplasmic antibody-related vasculitis: Case report and review of the literature","volume":"96","author":"Yanagiha","year":"2017","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MAJ.0b013e3182536789","article-title":"Microscopic polyangiitis with an initial presentation of pontine infarction","volume":"344","author":"Chen","year":"2012","journal-title":"Am J Med Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"NP1","DOI":"10.1177\/0883073813488661","article-title":"Microscopic polyangiitis presenting with hemorrhagic stroke","volume":"29","author":"Iglesias","year":"2014","journal-title":"J Child Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2005.07.003","article-title":"ANCA-associated vasculitis (AAV) causing bilateral cerebral infarction and subsequent intracerebral hemorrhage without renal and respiratory dysfunction","volume":"240","author":"Ito","year":"2006","journal-title":"J Neurol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1272\/jnms.84.251","article-title":"A case of microscopic polyangiitis with subarachnoid hemorrhage and cardiovascular complications","volume":"84","author":"Aratani","year":"2017","journal-title":"J Nippon Med Sch."},{"key":"B34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1148\/rg.344135028","article-title":"Imaging spectrum of CNS vasculitis","volume":"34","author":"Abdel","year":"2014","journal-title":"Radiographics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00296-010-1367-8","article-title":"Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis","volume":"32","author":"Fuentes","year":"2012","journal-title":"Rheumatol Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"bcr2013202022","DOI":"10.1136\/bcr-2013-202022","article-title":"Posterior reversible leukoencephalopathy syndrome as a presenting manifestation of p-ANCA-associated vasculitis","volume":"2014","author":"Patel","year":"2014","journal-title":"BMJ Case Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes","volume":"54","author":"De","year":"2015","journal-title":"Rheumatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10067-005-0065-5","article-title":"Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis","volume":"25","author":"Spisek","year":"2006","journal-title":"Clin Rheumatol."},{"key":"B39","first-page":"523","article-title":"Wegener granuloma in the fourth ventricle","volume":"24","author":"Berlis","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0022-510X(02)00015-1","article-title":"Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides","volume":"195","author":"Mattioli","year":"2002","journal-title":"J Neurol Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00415-017-8416-0","article-title":"Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis","volume":"264","author":"Choi","year":"2017","journal-title":"J Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"W619","DOI":"10.2214\/AJR.14.13864","article-title":"The many faces of granulomatosis with polyangiitis: a review of the head and neck imaging manifestations","volume":"205","author":"Pakalniskis","year":"2015","journal-title":"Am J Roentgenol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1210\/jc.2014-1962","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis: the mayo clinic experience","volume":"99","author":"Kapoor","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11102-017-0811-0","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis","volume":"20","author":"Esposito","year":"2017","journal-title":"Pituitary"},{"key":"B46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/RHU.0000000000000092","article-title":"Pituitary involvement in granulomatosis with polyangiitis","volume":"20","author":"Yong","year":"2014","journal-title":"J Clin Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1097\/MD.0000000000000748","article-title":"Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature","volume":"94","author":"De","year":"2015","journal-title":"Medicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.034","article-title":"Microscopic polyangiitis with spinal cord involvement: a case report and review of the literature","volume":"25","author":"Decker","year":"2016","journal-title":"J Stroke Cereb Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1042 e1","DOI":"10.1016\/j.wneu.2017.08.035","article-title":"Nontuberculous antineutrophil cytoplasmic antibody-positive pachymeningitis presenting as high cervical myelopathy","volume":"107","author":"Nair","year":"2017","journal-title":"World Neurosurg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10067-013-2420-2","article-title":"Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based review","volume":"34","author":"Soderstrom","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","article-title":"Vasculitic neuropathies","volume":"13","author":"Gwathmey","year":"2014","journal-title":"Lancet Neurol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00415-009-0121-1","article-title":"Cranial nerve palsy in Wegener's granulomatosis\u2013lessons from clinical cases","volume":"256","author":"Nowack","year":"2009","journal-title":"J Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations","volume":"5","author":"Kubaisi","year":"2016","journal-title":"Intractable Rare Dis Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ICU.0000000000000422","article-title":"Ophthalmologic manifestations of systemic vasculitis","volume":"28","author":"Papaliodis","year":"2017","journal-title":"Curr Opin Ophthalmol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-0034-1390393","article-title":"Ocular inflammation in neurorheumatic disease","volume":"34","author":"Vodopivec","year":"2014","journal-title":"Semin Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2009.119032","article-title":"EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis","volume":"69","author":"Basu","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.rdc.2010.05.001","article-title":"Autoantibodies in ANCA-associated vasculitis","volume":"36","author":"Wiik","year":"2010","journal-title":"Rheum Dis Clin North Am."},{"key":"B64","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrrheum.2014.78","article-title":"Current and emerging techniques for ANCA detection in vasculitis","volume":"10","author":"Csernok","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1128\/CDLI.10.5.769-774.2003","article-title":"Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis","volume":"10","author":"Segelmark","year":"2003","journal-title":"Clin Diagn Lab Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2013a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13075-017-1321-1","article-title":"Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse","volume":"19","author":"Morgan","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1681\/ASN.2014080817","article-title":"Accurate relapse prediction in ANCA-associated vasculitis-the search for the Holy Grail","volume":"26","author":"Specks","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00281-014-0431-y","article-title":"B cell-mediated pathogenesis of ANCA-mediated vasculitis","volume":"36","author":"Jennette","year":"2014","journal-title":"Semin Immunopathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneph.2014.254","article-title":"Clinical trials","volume":"11","author":"Tanna","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2215\/CJN.07340713","article-title":"Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis","volume":"9","author":"Pendergraft","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2215\/CJN.08821209","article-title":"Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"5","author":"Rhee","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/rheumatology\/ket257","article-title":"Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre","volume":"52","author":"Besada","year":"2013","journal-title":"Rheumatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.12688\/f1000research.8403.1","article-title":"Koster KJW","volume":"5","author":"Matthew","year":"2016","journal-title":"F1000Research"},{"key":"B82","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007057","article-title":"Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis","author":"Fortin","year":"2013","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T23:25:08Z","timestamp":1547076308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":83,"alternative-id":["10.3389\/fneur.2018.01166"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.01166","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"article-number":"1166"}}